Fetal karyotyping for chromosome abnormalities after an unexplained elevated maternal serum alpha-fetoprotein screening

Obstetrics and Gynecology

Volumn 86, Issue 2, 1995, Pages 248-254

  Feuchtbaum, Lisa B ^a,b,c   Cunningham, George ^a,b,c   Waller, D Kim ^a,b,c   Lustig, Linda S ^a,b,c   Tompkinson, D Gwynne ^a,b,c   Hook, Ernst B ^a,b,c  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CHROMOSOME ABERRATION; DIAGNOSTIC VALUE; FETUS; FETUS MALFORMATION; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCREENING TEST;

ADULT; ALPHA-FETOPROTEINS; AMNIOCENTESIS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; FETAL DISEASES; GENETIC SCREENING; HUMAN; KARYOTYPING; PREGNANCY;

EID: 0029045824     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(95)00155-K     Document Type: Article

References (24)

1. Aneuploidy with neural tube defects: Another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein
2. Neural tube defects and trisomy 18
3. Survey of neural tube defects in spontaneously aborted embryos
4. Fetal gastrointestinal and abdominal wall defects: Associated malformations and chromosomal abnormalities
5. Chromosomal abnormalities in fetuses with omphalocele. Significance of omphalocele contents
6. Fetal omphalocele: Associated malformations and chromosomal defects
7. Elevated maternal serum alpha-fetoprotein (MSAFP): Interpretation and follow-up
8. Prenatal fetal karyotyping and maternal serum alpha-fetoprotein screening
9. Risk of fetal chromosome anomalies in patients with elevated maternal serum alpha-fetoprotein
10. Assessment of routine amniocentesis for unexplained maternal serum alphafetoprotein elevations
11. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: Is lowering maternal age for amniocentesis preferable?
12. California's experience with low MSAFP results
13. Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy
14. Routine amniotic fluid alpha-fetoprotein measurement in 34,000 pregnancies
15. Prenatal differentiation of ventral abdominal wall defects: Are amniotic fluid markers useful adjuncts?
16. Ultrasound detection of fetal aneuploidy in patients with elevated maternal serum alpha-fetoprotein
17. Elevated maternal serum alpha-fetoprotein concentration and fetal chromosome abnormalities
18. A survey of diagnostic amniocentesis in Oxford from 1974-1981
19. Outcome of pregnancy in patients with unexplained elevated or low levels of maternal serum alpha-fetoprotein
20. Incidence of fetal chromosome abnormalities in 2264 low-risk women
21. The frequency of chromosome abnormalities detected in consecutive newborn studies
22. Prenatal diagnosis of chromosome abnormalities
23. The natural history of cytogenetically abnormal fetuses detected at midtrimester amniocentesis which are not terminated electively: New data and estimates of the excess and relative risk of late fetal death associated with 47,+21 and some other abnormal karyotypes
24. Chromosome abnormalities and spontaneous fetal deaths following amniocentesis: Further data and associations with maternal age